The calendar flip to January usually triggers a collective panic to suddenly drink gallons of water and run marathons. But ...

Drug developers are racing to design molecules that coax our cells into burning more energy even when we are sitting still, ...

The drug targets the PCSK9 protein, and could give millions of people a more affordable option to reduce their heart disease risk. By Gina Kolata Merck, the company that introduced statins to the ...

Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. NEW ORLEANS — A pill designed to further lower ...

The cost of sequencing DNA has dropped dramatically, and with technologies like CRISPR, gene editing is becoming more precise and powerful than ever. From curing genetic diseases to designing the next ...

The aim of immunotherapy strategies is to leverage cells in the patient's own immune system to destroy tumor cells. Using a preclinical model, scientists from the Institut Pasteur and Inserm ...

Cancer cells can brainwash their neighbors. Like the CIA deploying secret agents to turn an enemy, tumors use a similar strategy to manipulate nearby cells. The tumors’ agents are mitochondria, the ...

The morning-after pill helps prevent pregnancy after unprotected sex, but its efficacy differs depending on the user's body mass and the timing of when they take the medication. When you purchase ...

The pill showed "significant" reductions in airway obstruction after 26 weeks. The first oral pill for obstructive sleep apnea (OSA) could be around the corner after pharmaceutical company Apnimed Inc ...

The most commonly used and prescribed birth control pill in the U.S. was classified by the International Agency for Research on Cancer (IARC) at the World Health Organization (WHO) as carcinogenic. In ...

Share on Pinterest A Wegovy weight loss pill from Novo Nordisk is forthcoming, providing an alternative to injectable GLP-1 drugs. Mads Claus Rasmussen/Ritzau Scanpix/AFP via Getty Images Federal ...